Skip to contentC
ClearPoint Neuro, Inc.
C
CLPTClearPoint Neuro, Inc. Q3 2022 · 10-Q
Revenue$5.15M$5.15M+12.5% vs Q3 2021 Net Income-$3.79M-$3.79MN/M vs Q3 2021 EPS Diluted-$0.15-$0.15N/M vs Q3 2021 Gross Profit$3,679,000+21.0% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ClearPoint Neuro, Inc. · CIK 1285550 · Engraved from SEC EDGAR
Operating Cash Flowderived-$3,852,000N/M Free Cash Flowderived-$3,921,000N/M Margins · derivedGross margin71.5%+5.0 pt vs Q3 2021
Operating margin-73.7%+9.4 pt vs Q3 2021
Net margin-73.6%+13.4 pt vs Q3 2021
ended Sep 30, 2022 · filed Nov 8, 2022 · 39 d after period end